Loading…

The macrocyclic tetrapeptide [D‐Trp]CJ‐15,208 produces short‐acting κ opioid receptor antagonism in the CNS after oral administration

Background and Purpose Cyclic peptides are resistant to proteolytic cleavage, therefore potentially exhibiting activity after systemic administration. We hypothesized that the macrocyclic κ opioid receptor (KOR)‐selective antagonist [D‐Trp]CJ‐15,208 would demonstrate antagonist activity after system...

Full description

Saved in:
Bibliographic Details
Published in:British journal of pharmacology 2013-05, Vol.169 (2), p.426-436
Main Authors: Eans, Shainnel O, Ganno, Michelle L, Reilley, Kate J, Patkar, Kshitij A, Senadheera, Sanjeewa N, Aldrich, Jane V, McLaughlin, Jay P
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background and Purpose Cyclic peptides are resistant to proteolytic cleavage, therefore potentially exhibiting activity after systemic administration. We hypothesized that the macrocyclic κ opioid receptor (KOR)‐selective antagonist [D‐Trp]CJ‐15,208 would demonstrate antagonist activity after systemic, that is, s.c. and oral (per os, p. o.), administration. Experimental Approach C57BL/6J mice were pretreated with [D‐Trp]CJ‐15,208 s.c. or p.o. before administration of the KOR‐selective agonist U50,488 and the determination of antinociception in the warm‐water tail‐withdrawal assay. The locomotor activity of mice treated with [D‐Trp]CJ‐15,208 was determined by rotorod testing. Additional mice demonstrating cocaine conditioned place preference and subsequent extinction were pretreated daily with vehicle or [D‐Trp]CJ‐15,208 and then exposed to repeated forced swim stress or a single additional session of cocaine place conditioning before redetermining place preference. Key Results Pretreatment with [D‐Trp]CJ‐15,208 administered s.c. or p.o. dose‐dependently antagonized the antinociception induced by i.p. administration of U50,488 in mice tested in the warm‐water tail‐withdrawal assay for less than 12 and 6 h respectively. [D‐Trp]CJ‐15,208 also produced limited (
ISSN:0007-1188
1476-5381
DOI:10.1111/bph.12132